홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Acetate → 4-(4,4-Dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-10-yl)[1,2]oxaborolo[4,3-c]pyridin-1(3H)-ol

HRID 1774646
인쇄

반응식

HRID 1774646 반응식
CC1(C)CC2C=C3N(CCNC3=O)C=2C1.[Cl:16][C:17]1[CH:22]=[CH:21][N:20]=[C:19]([N:23]2[CH2:34][CH2:33][N:32]3[C:25](=[CH:26][C:27]4[CH2:28][C:29]([CH3:36])([CH3:35])[CH2:30][C:31]=43)[C:24]2=[O:37])[C:18]=1[CH:38]=[O:39].[BH4-].[Na+].B(O)(O)[B:43]([OH:45])[OH:44].CC([O-])=O.[K+]>CO.C(Cl)Cl.CCO.CC(C1C=C(C(C)C)C(C2C=CC=CC=2P(C2CCCCC2)C2CCCCC2)=C(C(C)C)C=1)C>[Cl:16][C:17]1[CH:22]=[CH:21][N:20]=[C:19]([N:23]2[CH2:34][CH2:33][N:32]3[C:25](=[CH:26][C:27]4[CH2:28][C:29]([CH3:36])([CH3:35])[CH2:30][C:31]=43)[C:24]2=[O:37])[C:18]=1[CH:38]=[O:39].[CH3:35][C:29]1([CH3:36])[CH2:28][C:27]2[CH:26]=[C:25]3[N:32]([CH2:33][CH2:34][N:23]([C:19]4[C:18]5[CH2:38][O:44][B:43]([OH:45])[C:17]=5[CH:22]=[CH:21][N:20]=4)[C:24]3=[O:37])[C:31]=2[CH2:30]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 5

HCID 517044Potassium AcetateHCID 4311764Sodium borohydrideHCID 10986154Diboron tetrahydroxide2회HCID 580442027,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-oneHCID 768540784-chloro-2-(7,7-dimethyl-1-oxo-1,3,4,6,7,8-hexahydro-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-2-yl)nicotinaldehyde

생성물 2

HCID 76854078
4-chloro-2-(7,7-dimethyl-1-oxo-1,3,4,6,7,8-hexahydro-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-2-yl)nicotinaldehyde
HCID 1236127574-(4,4-Dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-10-yl)[1,2]oxaborolo[4,3-c]pyridin-1(3H)-ol수율 53%

시약·촉매·용매 4

HCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl촉매HCID 702Ethanol용매HCID 887Methanol용매HCID 6344Dichloromethane용매

반응 조건

온도
0 °C

실험 절차

4-Chloro-2-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-10-yl}pyridine-3-carbaldehyde 107e was prepared following the procedures for intermediate 108a in U.S. Pat. No. 8,716,274, Example 108, Figure 8, and from 4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one from U.S. Pat. No. 8,729,072, Example 103e. To a solution of 107e (12.0 g, 35.0 mmol) in MeOH (40 mL) and DCM (40 mL) was added NaBH4 (1.83 g, 38.4 mmol) in batches at 0° C. The reaction mixture was stirred at 0° C. for 1 h, quenched with water and concentrated. The residue was partitioned between EA and brine. The organic layer was separated, dried over Na2SO4, filtered and concentrated. The crude product 4-Chloro-2-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-10-yl}pyridine-3-carbinol 107f was used in next step without further purification (9.6 g, 80%). A mixture of compound 107f (9.6 g, 27.8 mmol), tetrahydroxydiborane, hypodiboric acid (7.43 g, 83.5 mmol), Xphos-Pd-G2 (218 mg, 0.278 mmol), Xphos (321 mg, 0.556 mmol) and KOAc (6.85 g, 83.5 mmol) in EtOH (200 mL) was heated to 80° C. for 1 h and concentrated. The residue was dissolved in sat. K2CO3 (100 mL) and extracted with DCM 4 times. The organic phase was discarded and the aqueous layer was neutralized with conc. HCl. White precipitate evolved and the suspension was extracted with DCM. The organic layer was combined, dried over Na2SO4, filtered and concentrated to give 107g as a gray solid (6.21 g, 53%).

후처리

  1. customquenched with water
  2. concentrationconcentrated
  3. customThe residue was partitioned between EA and brine
  4. customThe organic layer was separated
  5. dry with materialdried over Na2SO4
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe crude product 4-Chloro-2-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-10-yl}pyridine-3-carbinol 107f was used in next step without further purification (9.6 g, 80%)
  9. temperaturewas heated to 80° C. for 1 h
  10. concentrationconcentrated
  11. dissolutionThe residue was dissolved in sat. K2CO3 (100 mL)
  12. extractionextracted with DCM 4 times
  13. customWhite precipitate
  14. extractionthe suspension was extracted with DCM
  15. dry with materialdried over Na2SO4
  16. filtrationfiltered
  17. concentrationconcentrated

출처 및 근거

ORD 기록
ord-36572b5a79224f89840b866eee87393f
출처 데이터셋
uspto-grants-2016_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09260415B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트